Velcade and blood lactate dehydrogenase increased Patient Reports March 18, 2010

Velcade Side Effects Report #5330630-4
Velcade side effect was reported by a Physician from FRANCE on May 03, 2007. Male patient, 65 years of age, weighting 156.5 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, blood lactate dehydrogenase increased, bronchitis

, clostridium difficile colitis, cytomegalovirus viraemia, depression

, epistaxis, headache

, infection in an immunocompromised host. Velcade dosage: 2.54 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, PREDNISOLONE, METHOTREXATE, BLEOMYCIN, GRANOCYTE, BACTRIM. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5332908-7
Velcade side effect was reported by a Physician from FRANCE on May 10, 2007. Male patient, 65 years of age, weighting 156.5 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, blood lactate dehydrogenase increased, clostridium difficile colitis, cytomegalovirus viraemia, depression

, haemorrhage, interstitial lung disease, legionella serology positive, memory impairment. Velcade dosage: 2.54 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, PREDNISONE, METHOTREXATE, BLEOMYCIN, GRANOCYTE, BACTRIM. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5369938-5
Velcade side effect was reported by a Physician from FRANCE on June 08, 2007. Male patient, 65 years of age, weighting 156.5 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, antibody test positive, blood lactate dehydrogenase increased, clostridium difficile colitis, cytomegalovirus viraemia, haemorrhage, interstitial lung disease, nasal congestion, opportunistic infection. Velcade dosage: 2.54 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, PREDNISONE, METHOTREXATE, BLEOMYCIN, GRANOCYTE, BACTRIM. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5424515-2
Velcade side effect was reported by a Physician from FRANCE on Aug 13, 2007. Male patient, 65 years of age, weighting 156.5 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, blood lactate dehydrogenase increased, bronchitis

, clostridium difficile colitis, cytomegalovirus viraemia, depression

, interstitial lung disease, memory impairment, nasal congestion. Velcade dosage: 2.54 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, PREDNISONE, METHOTREXATE, BLEOMYCIN, GRANOCYTE, BACTRIM. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4560858-2
Velcade side effect was reported by a Physician from on Jan 07, 2005. Female patient, 65 years of age, weighting 154.3 lb, was diagnosed with plasmacytoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: alpha 1 globulin decreased, asthenia, blood albumin increased, blood immunoglobulin a decreased, blood immunoglobulin g decreased, blood immunoglobulin m decreased, blood lactate dehydrogenase increased, c-reactive protein increased, electrophoresis protein abnormal. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with ZOMETA, ERYTHROPOIETIN, MORPHINE SULPHATE, ALLOPURINOL, PANTOZOL, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4618415-5
Velcade side effect was reported by a Physician from on Mar 10, 2005. Female patient, 65 years of age, weighting 145.5 lb, was diagnosed with plasmacytoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin increased, blood calcium decreased, blood immunoglobulin a decreased, blood immunoglobulin g decreased, blood immunoglobulin m decreased, blood lactate dehydrogenase increased, decreased appetite. Velcade dosage: unknown. During the same period patient was treated with ZOMETA, ERYTHROPOIETIN, MORPHINE SULPHATE, ALLOPURINOL, PANTOPRAZOLE, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5346868-6
Velcade side effect was reported by a Physician from GERMANY on May 22, 2007. Male patient, 58 years of age, was diagnosed with plasmacytoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, gamma-glutamyltransferase increased. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, ALLOPURINOL, TAVANIC. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4607676-4
Velcade side effect was reported by a Physician from on Mar 01, 2005. Female patient, 50 years of age, weighting 253.5 lb, was diagnosed with plasmacytoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, blood lactate dehydrogenase increased, cranial nerve palsies multiple, diplopia, headache

, malignant neoplasm progression, multiple myeloma

, proteinuria. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient died.

Velcade Side Effects Report #6002010-X
Velcade side effect was reported by a Physician from UNITED STATES on Dec 02, 2008. Female patient, 66 years of age, weighting 150.6 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, coagulopathy, intervertebral discitis, osteomyelitis, psoas abscess, staphylococcal abscess. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with BENDAMUSTINE, RITUXIMAB, GLUCOSAMINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5427669-7
Velcade side effect was reported by a Physician from JAPAN on Aug 06, 2007. Male patient, 71 years of age, weighting 105.8 lb, was diagnosed with multiple sclerosis

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, aspergillosis, basophil count decreased, blood alkaline phosphatase decreased, blood immunoglobulin g increased, blood lactate dehydrogenase increased, blood urea decreased, blood urea increased. Velcade dosage: 1.00 MG/M2, INTRAVENOUS; 1.40 MG, INTRAVENOUS. During the same period patient was treated with ZOMETA, BICARBONATE, NEUTROGIN, AMIKACIN SULPHATE, LASIX, VORICONAZOLE, RABEPRAZOLE. Patient died on 05/07/2007.

Velcade Side Effects Report #4722553-6
Velcade side effect was reported by a Health Professional from UNITED STATES on July 05, 2005. Male patient, 59 years of age, weighting 172.0 lb, was diagnosed with multiple sclerosis

and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain upper, acquired diaphragmatic eventration, activated partial thromboplastin time prolonged, blood albumin decreased, blood glucose increased, blood lactate dehydrogenase increased, blood magnesium increased, blood urea increased, computerised tomogram abnormal. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with ACETAMINOPHEN, AEROCHAMBER INHALATION INHALER, COMBIVENT, AMMONIUM LACTATE, ARTIFICIAL TEARS SOLUTION, BISACODYL, CALCIUM CARBONATE, CAMPHOR. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5707892-4
Velcade side effect was reported by a Physician from JAPAN on Apr 03, 2008. Female patient, 80 years of age, weighting 74.96 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, blood pressure decreased, blood uric acid increased, c-reactive protein increased, cardiac failure, condition aggravated, constipation

, depressed level of consciousness. Velcade dosage: 1.40 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FOSAMAX, ALDACTONE, DIFLUCAN, TENORMIN, ASPIRIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, PROTECADIN. Patient died on 10/24/2007.

Velcade Side Effects Report #5984815-4
Velcade side effect was reported by a Physician from JAPAN on Nov 20, 2008. Male patient, 78 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, blood cholinesterase decreased, blood lactate dehydrogenase increased, disease progression, gastrointestinal haemorrhage, hyperkalaemia, hypotension. Velcade dosage: 1.5 MG, INTRAVENOUS. During the same period patient was treated with CANDESARTAN CILEXETIL, ALLOPURINOL, KAYEXALATE, MOBIC, METHYCOBAL, PURSENNID, OXYCONTIN, MAGNESIUM OXIDE. Patient died on 10/15/2008.

Velcade Side Effects Report #4564674-7
Velcade side effect was reported by a Pharmacist from on Jan 17, 2005. Male patient, 77 years of age, weighting 172.0 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cholelithiasis, gamma-glutamyltransferase increased, liver function test abnormal. Velcade dosage: 2.4 MG, IV BOLUS. During the same period patient was treated with WARFARIN, ZOMETA, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5165149-7
Velcade side effect was reported by a Physician from PORTUGAL on Nov 13, 2006. Female patient, 76 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, cardiac failure, disease progression, infection

, neuropathy. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5523796-4
Velcade side effect was reported by a Physician from JAPAN on Nov 06, 2007. Female patient, 76 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, c-reactive protein increased, deep vein thrombosis

, neuropathy peripheral, neutrophil count decreased, pulmonary embolism

, pyrexia, tumour lysis syndrome. Velcade dosage: 1.90 MG, INTRAVENOUS ; 1.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LASIX, PIPERACILLIN AND TAZOBACTAM. Patient died.

Velcade Side Effects Report #5552382-5
Velcade side effect was reported by a Physician from JAPAN on Nov 28, 2007. Female patient, 76 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, c-reactive protein increased, deep vein thrombosis

, disease progression, neuropathy peripheral, neutrophil count decreased, platelet count decreased, pulmonary embolism

, pyrexia. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DEXAMETHASONE PHOSPHATE, LASIX, PIPERACILLIN AND TAZOBACTAM, NORVASC, MUCOSTA, LANSOPRAZOLE, RIZE. Patient died on 10/29/2007.

Velcade Side Effects Report #5633209-X
Velcade side effect was reported by a Physician from JAPAN on Feb 05, 2008. Female patient, 76 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: bedridden, blood lactate dehydrogenase increased, c-reactive protein increased, catheter related complication, deep vein thrombosis

, disease progression, immobile, neuropathy peripheral, neutrophil count decreased. Velcade dosage: 1.90 MG, 1.50 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DEXAMETHASONE PHOSPHATE, LASIX, PIPERACILLIN AND TAZOBACTAM, NORVASC, MUCOSTA, LANSOPRAZOLE. Patient died on 10/29/2007.

Velcade Side Effects Report #5458045-9
Velcade side effect was reported by a Physician from JAPAN on Sept 05, 2007. Female patient, 75 years of age, weighting 97.00 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, hypoaesthesia, nausea

, neutrophil count decreased, platelet count decreased, pyrexia. Velcade dosage: 1.66 MG, INTRAVENOUS; 1.28 MG, INTRAVENOUS. During the same period patient was treated with ACTONEL, METHYCOBAL, URALYT, KYTRIL. Patient recovered.

Velcade Side Effects Report #5480956-9
Velcade side effect was reported by a Physician from JAPAN on Sept 26, 2007. Female patient, 75 years of age, weighting 97.00 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, hypoaesthesia, nausea

, neutrophil count decreased, platelet count decreased, pyrexia. Velcade dosage: 1.66 MG, INTRAVENOS, 1.28 MG, INTRAVENOUS. During the same period patient was treated with ACTONEL, METHYCOBAL, URALYT, KYTRIL. Patient recovered.

Velcade Side Effects Report #5989301-3
Velcade side effect was reported by a Physician from JAPAN on Nov 25, 2008. Female patient, 74 years of age, weighting 112.4 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, liver disorder, platelet count decreased. Velcade dosage: 1.8 MG, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #6023767-8
Velcade side effect was reported by a Physician from JAPAN on Dec 12, 2008. Female patient, 74 years of age, weighting 112.4 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, liver disorder, platelet count decreased. Velcade dosage: 1.8 MG, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #4781674-2
Velcade side effect was reported by a Physician from GERMANY on Sept 12, 2005. Male patient, 74 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, clostridium colitis, epididymitis, gamma-glutamyltransferase increased, haemoglobin decreased, nervous system disorder, somnolence, urosepsis. Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DURAGESIC, RED BLOOD CELLS, CEFIXIME, PREDNIHEXAL, PANTOPRAZOLE, NEURONTIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4806868-9
Velcade side effect was reported by a Physician from GERMANY on Oct 04, 2005. Male patient, 74 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood immunoglobulin g increased, blood lactate dehydrogenase increased, c-reactive protein increased, clostridium colitis, epididymitis, gamma-glutamyltransferase increased, haemoglobin decreased, platelet count decreased. Velcade dosage: 1.80 MG, IV BOLUS. During the same period patient was treated with DEXAMETHASONE, DURAGESIC, RED BLOOD CELLS, CEFIXIME, PREDNIHEXAL, PANTOPRAZOLE, NEURONTIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4806908-7
Velcade side effect was reported by a Physician from GERMANY on Oct 04, 2005. Male patient, 74 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood creatinine increased, blood immunoglobulin g increased, blood lactate dehydrogenase increased, c-reactive protein increased, clostridium colitis, epididymitis, gamma-glutamyltransferase increased, haemoglobin decreased. Velcade dosage: 1.80 MG, IV BOLUS. During the same period patient was treated with DEXAMETHASONE, DURAGESIC, RED BLOOD CELLS, CEFIXIME, PREDNIHEXAL, PANTOPRAZOLE, NEURONTIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5588249-6
Velcade side effect was reported by a Physician from JAPAN on Dec 28, 2007. Male patient, 73 years of age, weighting 158.7 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, bacterial infection

, blood lactate dehydrogenase increased, lung disorder, platelet count decreased. Velcade dosage: 2.3 MG, INTRAVENOUS; 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient recovered.

Velcade Side Effects Report #6050733-9
Velcade side effect was reported by a Physician from JAPAN on Jan 08, 2009. Female patient, 73 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, c-reactive protein increased, capillary leak syndrome, constipation

, hyperphosphatasaemia, hyponatraemia, hypotension, non-cardiogenic pulmonary oedema. Velcade dosage: 1.8 MG, INTRAVENOUS; 1.5 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LAXOBERON, SENNOSIDE A, SORBITOL, LECICARBON, MAGNESIUM OXIDE, DOPAMINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6111536-X
Velcade side effect was reported by a Physician from ITALY on Feb 25, 2009. Female patient, 73 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, atrial fibrillation

, blood lactate dehydrogenase increased. Velcade dosage: 2.23 MG. During the same period patient was treated with DEXAMETHASONE, METOPROLOL TARTRATE, EUTIROX, ZANTAC, TRAMADOL, CARDIOASPRIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6125896-7
Velcade side effect was reported by a Physician from ITALY on Mar 08, 2009. Female patient, 73 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, atrial fibrillation

, blood lactate dehydrogenase increased, cardiac disorder, muscle disorder

. Velcade dosage: 2.2 MG,. During the same period patient was treated with DEXAMETHASONE, METOPROLOL TARTRATE, EUTIROX, ZANTAC, TRAMADOL, ASPIRIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5084833-7
Velcade side effect was reported by a Physician from SPAIN on Aug 04, 2006. Male patient, 72 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal distension, agitation, asthenia, blood calcium decreased, blood glucose increased, blood lactate dehydrogenase increased, blood ph increased, blood phosphorus decreased, blood potassium increased. Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with MELPHALAN, PREDNISONE, FENTANYL, OMEPRAZOLE, LEVOFLOXACIN, PRETERAX, VORICONAZOLE. Patient was hospitalized and became disabled. Patient died on 06/16/2005.

Velcade Side Effects Report #4975854-0
Velcade side effect was reported by a Physician from SPAIN on Mar 29, 2006. Male patient, 72 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal distension, agitation, bacteria urine identified, blood bicarbonate increased, blood calcium decreased, blood glucose increased, blood immunoglobulin g increased, blood lactate dehydrogenase increased, blood ph increased. Velcade dosage: 2.00 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with MELPHALAN, PREDNISONE, FENTANYL, OMEPRAZOLE, LEVOFLOXACIN, PRETERAX, VORICONAZOLE. Patient was hospitalized and became disabled. Patient died on 06/16/2005.

Velcade Side Effects Report #5203398-X
Velcade side effect was reported by a Physician from JAPAN on Dec 26, 2006. Male patient, 71 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspergillosis, blood alkaline phosphatase decreased, blood lactate dehydrogenase increased, blood urea increased, blood uric acid increased, febrile neutropenia, hyperkalaemia, hypocalcaemia, pleural effusion. Velcade dosage: 1.40 MG/M2, INTRAVENOUS. During the same period patient was treated with GAMIMUNE. Patient recovered.

Velcade Side Effects Report #5218371-5
Velcade side effect was reported by a Physician from JAPAN on Jan 10, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: basophil count decreased, blood alkaline phosphatase decreased, blood lactate dehydrogenase increased, blood urea increased, blood uric acid increased, computerised tomogram thorax abnormal, febrile neutropenia, fungus serology test positive, haemoglobin decreased. Velcade dosage: 1.40 MG, INTRAVENOUS. During the same period patient was treated with ZOMETA, BICARBONATE, NEUTROGIN, AMIKACIN SULPHATE, LASIX, VORICONAZOLE, RABEPRAZOLE, ENALAPRIL MALEATE. Patient recovered.

Velcade Side Effects Report #5225693-0
Velcade side effect was reported by a Physician from JAPAN on Jan 12, 2007. Female patient, 71 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, bone marrow failure, haemorrhage, interstitial lung disease, pleural effusion, pneumonia aspiration. Velcade dosage: 1.80 MG; 1.40 MG. During the same period patient was treated with DECADRON, SAURAMIDE, FAMOTIDINE, SULFAMETHOXAZOLE, THALIDOMIDE. Patient died on 01/07/2007.

Velcade Side Effects Report #5226890-0
Velcade side effect was reported by a Physician from JAPAN on Jan 18, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: basophil count decreased, blood alkaline phosphatase decreased, blood lactate dehydrogenase increased, blood urea increased, blood uric acid increased, c-reactive protein decreased, computerised tomogram thorax, febrile neutropenia, fungal dna test positive. Velcade dosage: 1.40 MG, INTRAVENOUS. During the same period patient was treated with ZOMETA, BICARBONATE, NEUTROGIN, AMIKACIN SULPHATE, LASIX, VORICONAZOLE, RABEPRAZOLE, ENALAPRIL MALEATE. Patient recovered.

Velcade Side Effects Report #5228546-7
Velcade side effect was reported by a Physician from JAPAN on Jan 19, 2007. Female patient, 71 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: atelectasis, blood lactate dehydrogenase increased, bone marrow failure, haemorrhage, infection

, interstitial lung disease, oedema peripheral, pleural effusion, pneumonia aspiration. Velcade dosage: 1.80 MG, SEE IMAGE. During the same period patient was treated with DECADRON, SAURAMIDE, FAMOTIDINE, BAKTAR, THALIDOMIDE. Patient died on 01/07/2007.

Velcade Side Effects Report #5235164-3
Velcade side effect was reported by a Physician from JAPAN on Jan 26, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase decreased, blood glucose increased, blood lactate dehydrogenase increased, blood urea decreased, blood urea increased, blood uric acid increased, c-reactive protein increased, computerised tomogram thorax abnormal, febrile neutropenia. Velcade dosage: 1.40 MG, INTRAVENOUS. During the same period patient was treated with ZOMETA, BICARBONATE, NEUTROGIN, AMIKACIN SULPHATE, LASIX, VORICONAZOLE, RABEPRAZOLE, ENALAPRIL MALEATE. Patient recovered.

Velcade Side Effects Report #5247691-3
Velcade side effect was reported by a Physician from JAPAN on Feb 02, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase decreased, blood glucose increased, blood lactate dehydrogenase increased, blood urea increased, blood uric acid increased, c-reactive protein increased, computerised tomogram thorax abnormal, febrile neutropenia, fungal dna test positive. Velcade dosage: 1.40 MG, INTRAVENOUS. During the same period patient was treated with ZOMETA, BICARBONATE, NEUTROGIN, AMIKACIN SULPHATE, LASIX, VORICONAZOLE, RABEPRAZOLE, ENALAPRIL MALEATE. Patient recovered.

Velcade Side Effects Report #5261520-3
Velcade side effect was reported by a Physician from JAPAN on Feb 19, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: basophil count decreased, blood alkaline phosphatase decreased, blood lactate dehydrogenase increased, blood urea increased, blood uric acid increased, c-reactive protein increased, computerised tomogram thorax abnormal, febrile neutropenia, fungal dna test positive. Velcade dosage: 1.4 MG, INTRAVENOUS. During the same period patient was treated with ZOMETA, BICARBONATE, NEUTROGIN, AMIKACIN SULPHATE, LASIX, VORICONAZOLE, RABEPRAZOLE, ENALAPRIL MALEATE. Patient recovered.

Velcade Side Effects Report #5332903-8
Velcade side effect was reported by a Physician from JAPAN on May 08, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: basophil count decreased, blood alkaline phosphatase decreased, blood glucose increased, blood lactate dehydrogenase increased, blood urea increased, blood uric acid increased, computerised tomogram thorax abnormal, condition aggravated, febrile neutropenia. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with ZOMETA, BICARBONATE, NEUTROGIN, AMIKACIN SULPHATE, LASIX, VORICONAZOLE, RABEPRAZOLE, ENALAPRIL MALEATE. Patient died on 05/07/2007.

Velcade Side Effects Report #5341862-3
Velcade side effect was reported by a Physician from JAPAN on May 16, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: basophil count decreased, blood alkaline phosphatase decreased, blood glucose increased, blood immunoglobulin g increased, blood lactate dehydrogenase increased, blood urea decreased, blood urea increased, blood uric acid increased, c-reactive protein increased. Velcade dosage: 1.00 MG/M2, UNK, INTRAVENOUS. During the same period patient was treated with ZOMETA, BICARBONATE, NEUTROGIN, AMIKACIN SULPHATE, LASIX, VORICONAZOLE, RABEPRAZOLE, ENALAPRIL MALEATE. Patient died on 05/07/2007.

Velcade Side Effects Report #5368126-6
Velcade side effect was reported by a Physician from JAPAN on June 06, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation

, blood lactate dehydrogenase increased, c-reactive protein increased, diarrhoea, hypovolaemia, platelet count decreased, pleural effusion, pyrexia, rash

. Velcade dosage: 2.20 MG,. During the same period patient was treated with PREDNISOLONE, ITRACONAZOLE, ALLOPURINOL, MUCOSTA, ZANTAC, BICARBONATE IN PLASTIC CONTAINER, ADOFEED, LOXONIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5376669-4
Velcade side effect was reported by a Physician from JAPAN on June 18, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspergillosis, blood alkaline phosphatase decreased, blood glucose increased, blood lactate dehydrogenase increased, blood urea increased, blood uric acid increased, c-reactive protein increased, congestive cardiomyopathy, febrile neutropenia. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with ZOMETA, BICARBONATE, NEUTROGIN, AMIKACIN SULPHATE, LASIX, VORICONAZOLE, RABEPRAZOLE, ENALAPRIL MALEATE. Patient died on 05/07/2007.

Velcade Side Effects Report #5451071-5
Velcade side effect was reported by a Physician from JAPAN on Aug 30, 2007. Female patient, 71 years of age, weighting 79.37 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, c-reactive protein increased, cardiac failure, hypotension, pleural effusion. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with LASIX, OMEPRAZOLE, ALLOPURINOL, SELBEX, ZOLPIDEM TARTRATE, VERAPAMIL HYDROCHLORIDE, TAMBOCOR. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5466070-7
Velcade side effect was reported by a Physician from JAPAN on Sept 07, 2007. Male patient, 71 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation

, blood lactate dehydrogenase increased, c-reactive protein increased, diarrhoea, disease progression, hypovolaemia, lymphocyte count decreased, platelet count decreased, pleural effusion. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, ITRACONAZOLE, ALLOPURINOL, MUCOSTA, ZANTAC, BICARBONATE IN PLASTIC CONTAINER, ADOFEED, LOXONIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5485964-X
Velcade side effect was reported by a Physician from JAPAN on Oct 01, 2007. Male patient, 71 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma

, prophylaxis and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation

, blood lactate dehydrogenase increased, c-reactive protein increased, diarrhoea, disease progression, hypovolaemia, lymphocyte count decreased, platelet count decreased, pleural effusion. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with BAKTAR, PREDNISOLONE, ITRACONAZOLE, ALLOPURINOL, MUCOSTA, ZANTAC, BICARBONATE IN PLASTIC CONTAINER, ADOFEED. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5533895-9
Velcade side effect was reported by a Physician from JAPAN on Nov 13, 2007. Male patient, 71 years of age, weighting 105.8 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, basophil count decreased, blood alkaline phosphatase decreased, blood lactate dehydrogenase increased, blood urea decreased, blood urea increased, blood uric acid increased, c-reactive protein increased. Velcade dosage: 1.00 MG/M2, INTRAVENOUS; 1.40 MG, INTRAVENOUS. During the same period patient was treated with ZOMETA, BICARBONATE, NEUTROGIN, AMIKACIN SULPHATE, LASIX, VORICONAZOLE, RABEPRAZOLE. Patient died on 05/07/2007.

Velcade Side Effects Report #5570184-0
Velcade side effect was reported by a Physician from JAPAN on Dec 05, 2007. Male patient, 71 years of age, weighting 105.8 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorectal disorder, basophil count decreased, bladder disorder, blood alkaline phosphatase decreased, blood lactate dehydrogenase increased, blood urea increased, blood uric acid increased, c-reactive protein increased, computerised tomogram abnormal. Velcade dosage: 1.00 MG/M2, INTRAVENOUS; 1.40 MG, INTRAVENOUS. During the same period patient was treated with ZOMETA, BICARBONATE, NEUTROGIN, AMIKACIN SULPHATE, LASIX, VORICONAZOLE, RABEPRAZOLE. Patient died on 05/07/2007.

Velcade Side Effects Report #5615693-0
Velcade side effect was reported by a Physician from JAPAN on Jan 22, 2008. Male patient, 71 years of age, weighting 105.8 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, basophil count decreased, blood alkaline phosphatase decreased, blood lactate dehydrogenase increased, blood urea increased, blood uric acid increased, c-reactive protein increased, febrile neutropenia. Velcade dosage: 1.00 MG/M2, INTRAVENOUS; 1.40 MG, INTRAVENOUS. During the same period patient was treated with ZOMETA, BICARBONATE, NEUTROGIN, AMIKACIN SULPHATE, LASIX, VORICONAZOLE, RABEPRAZOLE. Patient died on 05/07/2007.

Velcade Side Effects Report #5679631-7
Velcade side effect was reported by a Physician from JAPAN on Mar 12, 2008. Male patient, 71 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma

, prophylaxis and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation

, blood lactate dehydrogenase increased, c-reactive protein increased, diarrhoea, disease progression, platelet count decreased, pleural effusion, pyrexia, rash

. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM, PREDNISOLONE, ITRACONAZOLE, ALLOPURINOL, MUCOSTA, ZANTAC, BICARBONATE IN PLASTIC CONTAINER, ADOFEED. Patient was hospitalized. Patient died on 08/23/2007.

Velcade Side Effects Report #5746163-7
Velcade side effect was reported by a Physician from JAPAN on May 08, 2008. Male patient, 71 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, blood uric acid increased, diarrhoea, eosinophilia, gait disturbance, hypoaesthesia, hypokalaemia. Velcade dosage: 2 MG, INTRAVENOUS; 1.5 MG, INTRAVENOUS. During the same period patient was treated with GLYBURIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5798874-5
Velcade side effect was reported by a Physician from JAPAN on June 18, 2008. Male patient, 71 years of age, weighting 101.4 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood phosphorus increased, disseminated intravascular coagulation, gingival bleeding, herpes zoster, interstitial lung disease, myasthenia gravis, oxygen saturation decreased, pleural effusion. Velcade dosage: 1.8 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ZANTAC, LENDORM, MUCOSTA, PIPERACILLIN, SEISHOKU. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6049538-4
Velcade side effect was reported by a Physician from JAPAN on Jan 09, 2009. Female patient, 71 years of age, weighting 79.37 lb, was diagnosed with multiple myeloma

, goitre. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with LASIX, OMEPRAZOLE, ALLOPURINOL, SELBEX, ZOLPIDEM TARTRATE, VERAPAMIL HYDROCHLORIDE, TAMBOCOR, THALIDOMIDE. Patient was hospitalized. Patient died on 01/31/2008.

Velcade Side Effects Report #6053881-2
Velcade side effect was reported by a Physician from JAPAN on Jan 15, 2009. Female patient, 71 years of age, weighting 79.37 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, arteriosclerosis coronary artery, blood creatinine increased, blood lactate dehydrogenase increased, blood sodium decreased, blood urea increased, bronchopneumonia, condition aggravated, disseminated intravascular coagulation. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with LASIX, OMEPRAZON, ALLOPURINOL, SELBEX, ZOLPIDEM TARTRATE, VERAPAMIL HYDROCHLORIDE, TAMBOCOR, THALIDOMIDE. Patient was hospitalized. Patient died.

Velcade Side Effects Report #5259535-4
Velcade side effect was reported by a Physician from UNITED STATES on Feb 22, 2007. Female patient, 70 years of age, weighting 145.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, asthenia, back pain

, blood lactate dehydrogenase increased, burning sensation, disease progression, dry skin, dyspnoea, ecchymosis. Velcade dosage: unknown. During the same period patient was treated with REVLIMID, DEXAMETHASONE, ASPIRIN. Patient recovered.

Velcade Side Effects Report #5460703-7
Velcade side effect was reported by a Physician from JAPAN on Sept 07, 2007. Male patient, 70 years of age, weighting 115.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood uric acid increased, diarrhoea, infection

, platelet count decreased, pyrexia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS; 2.00 MG, INTRAVENOUS. During the same period patient was treated with ORGADRONE, ASPIRIN, ALLOPURINOL, KYTRIL, EPOGEN, MAXIPIME, ZOMETA. Patient recovered.

Velcade Side Effects Report #5503607-3
Velcade side effect was reported by a Physician from JAPAN on Oct 17, 2007. Male patient, 70 years of age, weighting 115.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood uric acid increased, diarrhoea, infection

, platelet count decreased, pyrexia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS; 2.00 MG, INTRAVENOUS. During the same period patient was treated with ORGADRONE, ASPIRIN, ALLOPURINOL, KYTRIL, EPOGIN, MAXIPIME, ZOMETA. Patient recovered.

Velcade Side Effects Report #5954226-6
Velcade side effect was reported by a Physician from JAPAN on Oct 31, 2008. Male patient, 70 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, asthenia, blood calcium decreased, blood chloride increased, blood lactate dehydrogenase increased, blood urea increased, bone marrow disorder, disease progression, gastrointestinal haemorrhage. Velcade dosage: 1.9 MG, UNK, INTRAVENOUS. During the same period patient was treated with CEFTAZIDIME, RED BLOOD CELLS. Patient died on 12/26/2006.

Velcade Side Effects Report #4767085-4
Velcade side effect was reported by a Physician from AUSTRALIA on Aug 24, 2005. Female patient, 70 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: atelectasis, blood alkaline phosphatase increased, blood bicarbonate decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium decreased, blood urea increased, blood uric acid increased. Velcade dosage: 20.00 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DOXIL, ENOXAPARIN, OXYGEN, ALBUTEROL, ANTICOAGULANT CITRATE, ANALGESICS, ANTIBIOTICS. Patient was hospitalized. Patient died on 07/24/2005.

Velcade Side Effects Report #4830952-7
Velcade side effect was reported by a Physician from AUSTRALIA on Aug 24, 2005. Female patient, 70 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bicarbonate decreased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium decreased, confusional state, diarrhoea. Velcade dosage: 20.00 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DOXIL, ENOXAPARIN, OXYGEN, ALBUTEROL, ANTICOAGULANT CITRATE DEXTROSE, ANALGESICS, ANTIBIOTICS. Patient was hospitalized. Patient died on 07/24/2005.

Velcade Side Effects Report #5531246-7
Velcade side effect was reported by a Physician from NETHERLANDS on Nov 13, 2007. Female patient, 69 years of age, weighting 213.8 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, chest pain

, chills, dyspnoea, pyrexia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #5843060-3
Velcade side effect was reported by a Physician from JAPAN on July 29, 2008. Female patient, 69 years of age, weighting 110.2 lb, was diagnosed with multiple myeloma

, herpes zoster and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, dyspnoea, herpes zoster, malaise, neurogenic bladder, platelet count decreased. Velcade dosage: 1.4 MG UNK INTRAVENOUS. During the same period patient was treated with ZOVIRAX, DEXAMETHASONE. Patient recovered.

Velcade Side Effects Report #4626415-4
Velcade side effect was reported by a Physician from on Mar 18, 2005. Female patient, 69 years of age, was diagnosed with multiple myeloma

, multiple sclerosis

and was treated with Velcade. After drug was administered, patient experienced the following side effects: bacterial sepsis, blood lactate dehydrogenase increased, blood potassium decreased, haemodynamic instability, multi-organ failure, pneumonia

, respiratory failure. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient died on 07/29/2004.

Velcade Side Effects Report #5122017-4
Velcade side effect was reported by a Physician from UNITED STATES on Sept 22, 2006. Female patient, 68 years of age, weighting 113.5 lb, was diagnosed with multiple myeloma

, cytomegalovirus oesophagitis, disease progression. Velcade dosage: 1.30 MG/M2,UNK, UNK. During the same period patient was treated with DOXIL, ESCITALOPRAM OXALATE, DEXAMETHASONE, FLUCONAZOLE, ACYCLOVIR, MORPHINE, RANITIDINE, COMPAZINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5130140-3
Velcade side effect was reported by a Physician from UNITED STATES on Oct 02, 2006. Female patient, 68 years of age, weighting 113.5 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood sodium decreased, blood urea increased, confusional state, convulsion, cytomegalovirus oesophagitis, dysphagia, encephalitis cytomegalovirus. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DOXIL, ESCITALOPRAM OXALATE, DEXAMETHASONE, FLUCONAZOLE, ACYCLOVIR, MORPHINE, RANITIDINE, COMPAZINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5143547-5
Velcade side effect was reported by a Physician from UNITED STATES on Oct 17, 2006. Female patient, 68 years of age, weighting 113.5 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood chloride decreased, blood lactate dehydrogenase increased, blood sodium decreased, blood urea increased, confusional state, convulsion, cytomegalovirus oesophagitis, dysphagia. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DOXORUBICIN, ESCITALOPRAM OXALATE, DEXAMETHASONE, FLUCONAZOLE, ACYCLOVIR, MORPHINE, RANITIDINE, COMPAZINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5191870-0
Velcade side effect was reported by a Physician from UNITED STATES on Dec 07, 2006. Female patient, 68 years of age, weighting 113.5 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: bacteria stool identified, blood chloride decreased, blood lactate dehydrogenase increased, blood sodium decreased, blood urea increased, clostridial infection, confusional state, convulsion, cytomegalovirus oesophagitis. Velcade dosage: unknown. During the same period patient was treated with DOXORUBICIN, ESCITALOPRAM OXALATE, DEXAMETHASONE, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5912575-1
Velcade side effect was reported by a Pharmacist from AUSTRALIA on Sept 30, 2008. Female patient, 68 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, back pain

, blood lactate dehydrogenase increased, malaise, no therapeutic response. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, QUETIAPINE FUMARATE, BACTRIM DS, CLODRONATE DI, PAROXETINE, VALTREX, ALLOPURINOL, GRANULOCYTE COLONY STIMULATING FACTOR. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6020649-2
Velcade side effect was reported by a Pharmacist from AUSTRALIA on Dec 09, 2008. Female patient, 68 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, back pain

, blood lactate dehydrogenase increased, lower respiratory tract infection, malaise, pulmonary oedema. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, QUETIAPINE FUMARATE, BACTRIM DS, CLODRONATE DI, PAROXETINE, VALTREX, ALLOPURINOL, NEUPOGEN. Patient was hospitalized. Patient died on 10/23/2008.

Velcade Side Effects Report #6131816-1
Velcade side effect was reported by a Physician from JAPAN on Mar 12, 2009. Male patient, 68 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, bone marrow failure, bronchoalveolar lavage abnormal, candidiasis, enterococcal infection, pneumonia

, pulmonary oedema, respiratory disorder, tumour lysis syndrome. Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with ITRACONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DIURETICS, DECADRON, ZOMETA. Patient died on 08/14/2008.

Velcade Side Effects Report #4685606-7
Velcade side effect was reported by a Physician from on May 20, 2005. Female patient, 68 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood glucose increased, blood lactate dehydrogenase increased, blood sodium decreased, bronchiectasis, decreased appetite, diarrhoea. Velcade dosage: unknown. During the same period patient was treated with BONALON, GASTER OD, MUCOSTA, ALFAROL, LOXONIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4690068-X
Velcade side effect was reported by a Physician from on May 31, 2005. Female patient, 68 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, blood calcium decreased, blood creatine phosphokinase increased, blood creatinine increased, blood glucose increased, blood lactate dehydrogenase increased, blood sodium decreased. Velcade dosage: 1.94 MG, 2/WEEK, IV BOLUS. During the same period patient was treated with BONALON, GASTER OD, MUCOSTA, ALFAROL, LOXONIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4744332-6
Velcade side effect was reported by a Physician from JAPAN on July 27, 2005. Female patient, 68 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, blood bicarbonate decreased, blood creatine phosphokinase increased, blood glucose increased, blood lactate dehydrogenase increased, blood sodium decreased, bronchiectasis. Velcade dosage: 1.94 MG, 2/WEEK/IV BOLUS; 1.91 MG, 2/WEEK, IV BOLUS. During the same period patient was treated with BONALON, GASTER OD, MUCOSTA, ALFAROL, LOXONIN, AMINOFLUID, VITAJECT. Patient was hospitalized. Patient died on 07/12/2005.

Velcade Side Effects Report #4774964-0
Velcade side effect was reported by a Physician from FRANCE on Sept 06, 2005. Female patient, 68 years of age, weighting 92.59 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, febrile bone marrow aplasia, gamma-glutamyltransferase increased, histiocytosis haematophagic, lymphopenia, protein total increased, renal failure, serum ferritin increased. Velcade dosage: 1.35 MG , 2/WEEK, IV BOLUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4805496-9
Velcade side effect was reported by a Physician from CANADA on Oct 03, 2005. Female patient, 68 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: arrhythmia

, atrioventricular block complete, atrioventricular block first degree, blood albumin decreased, blood lactate dehydrogenase increased, bradycardia, bundle branch block left, bundle branch block right, cardiac arrest

. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with HYDROMORPH CONTIN, CYCLOGYL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4932656-9
Velcade side effect was reported by a Physician from CANADA on Feb 14, 2006. Female patient, 68 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: angina pectoris, arrhythmia

, atrioventricular block complete, atrioventricular block first degree, autoimmune disorder, blood albumin decreased, blood lactate dehydrogenase increased, bradycardia, bundle branch block left. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with HYDROMORPH CONTIN, CYCLOGYL, PREDTE, ATORVASTATIN CALCIUM, FUROSEMIDE, PROCHLORPERAZINE, OMEPRAZOLE, PAMIDRONATE DI. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4975856-4
Velcade side effect was reported by a Physician from CANADA on Mar 29, 2006. Female patient, 68 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: angina pectoris, anuria, arrhythmia

, blood albumin decreased, blood calcium decreased, blood lactate dehydrogenase increased, bradycardia, bundle branch block left, bundle branch block right. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with HYDROMORPH CONTIN, CYCLOGY L, PREDTE, ATORVASTATIN CALCIUM, FUROSEMIDE, PROCHLORPERAZINE, OMEPRAZOLE, PAMIDRONATE DI. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5123305-8
Velcade side effect was reported by a Physician from JAPAN on Sept 21, 2006. Female patient, 67 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood calcium decreased, blood creatinine increased, blood lactate dehydrogenase increased, depressed level of consciousness, hepatic failure, incoherent, interleukin level increased, metastases to liver. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient died on 09/01/2005.

Velcade Side Effects Report #5139676-2
Velcade side effect was reported by a Physician from JAPAN on Oct 11, 2006. Female patient, 67 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood calcium decreased, blood creatinine increased, blood lactate dehydrogenase increased, depressed level of consciousness, incoherent, interleukin level increased, metastases to liver, oesophageal cancer metastatic. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient died on 09/01/2005.

Velcade Side Effects Report #5504715-3
Velcade side effect was reported by a Physician from JAPAN on Oct 19, 2007. Male patient, 67 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, blood uric acid increased, condition aggravated, disease progression, gastrointestinal haemorrhage, haemorrhagic diathesis, multiple myeloma

. Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, BETAMETHASONE, ORGARAN. Patient died on 09/10/2007.

Velcade Side Effects Report #5857240-4
Velcade side effect was reported by a Physician from JAPAN on Aug 14, 2008. Male patient, 67 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, disease progression, dysuria, pneumonia

, sciatica

. Velcade dosage: 1.5 MG, INTRAVENOUS; 1.9 MG, INTRAVENOUS. During the same period patient was treated with OXYCODONE, DEXAMETHASONE, PLATELETS, RED BLOOD CELLS, ZOMETA. Patient died on 12/16/2007.

Velcade Side Effects Report #5959592-3
Velcade side effect was reported by a Physician from JAPAN on Nov 04, 2008. Male patient, 67 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, bone marrow failure, bone pain, dehydration, pulmonary oedema, sepsis

, tumour lysis syndrome, white blood cell count decreased. Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with ITRACONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DIURETICS, DEXAMETHASONE, ZOMETA. Patient died on 08/14/2008.

Velcade Side Effects Report #4748413-2
Velcade side effect was reported by a Health Professional from UNITED STATES on Aug 02, 2005. Male patient, 67 years of age, weighting 179.9 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, hypoaesthesia, pyrexia, rhinorrhoea, thrombocytopenia. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, PRAVACHOL, COLCHICINE. Patient recovered.

Velcade Side Effects Report #4753318-7
Velcade side effect was reported by a Pharmacist from UNITED STATES on June 01, 2005. Female patient, 67 years of age, weighting 170.4 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: aggression, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood calcium increased, blood lactate dehydrogenase increased, blood urea increased, communication disorder, confusional state. Velcade dosage: 1.63 MG, UNK, IV BOLUS. During the same period patient was treated with DECADRON, AREDIA, VITAMINS, LOZOL, CLONIDINE, ALBUTEROL, ACYCLOVIR. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5504697-4
Velcade side effect was reported by a Physician from JAPAN on Oct 19, 2007. Male patient, 66 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood lactate dehydrogenase increased, constipation

, enterocolitis, hypoaesthesia, lymphocyte count decreased, neutrophil count decreased, oedema. Velcade dosage: 2.00 MG, INTRAVENOUS, 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DECADRON, LEVOFLOXACIN, BAKTAR, LAXOBERON, SENNOSIDE A, PANTOSIN, PLATELETS. Patient recovered.

Velcade Side Effects Report #5584731-6
Velcade side effect was reported by a Physician from JAPAN on Dec 19, 2007. Male patient, 66 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma

, disease progression, enterocolitis, hypoaesthesia, lymphocyte count decreased, malignant neoplasm progression. Velcade dosage: 2.00 MG, INTRAVENOUS : 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DECADRON, LEVOFLOXACIN, BAKTAR, LAXOBERON, SENNOSIDE A, PANTOSIN, PLATELETS. Patient recovered.

Velcade Side Effects Report #4774963-9
Velcade side effect was reported by a Physician from NETHERLANDS on Sept 05, 2005. Female patient, 66 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood sodium decreased, haemoglobin decreased, hepatic function abnormal, hyperglycaemia. Velcade dosage: 2.60 + 2.00MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with AMARYL, ACTOS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4814321-1
Velcade side effect was reported by a Physician from AUSTRALIA on Oct 12, 2005. Male patient, 66 years of age, weighting 209.4 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: back pain

, blood albumin increased, blood lactate dehydrogenase increased, chest x-ray abnormal, disease recurrence, dyspnoea, haematocrit decreased, haemoglobin decreased, international normalised ratio increased. Velcade dosage: 2.40 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, ALLOPURINOL, FLUCONAZOLE, PERINDOPRIL, INDAPAMIDE, ACYCLOVIR, PANTOPRAZOLE, BACTRIM DS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4871872-1
Velcade side effect was reported by a Physician from AUSTRALIA on Dec 20, 2005. Male patient, 66 years of age, weighting 209.4 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: back pain

, blood albumin decreased, blood lactate dehydrogenase increased, haematocrit decreased, haemoglobin decreased, international normalised ratio increased, lymphocyte count decreased, macrocytosis, mean cell haemoglobin increased. Velcade dosage: 2.40 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, ALLOPURINOL, FLUCONAZOLE, PERINDOPRIL, INDAPAMIDE, ACYCLOVIR, PANTOPRAZOLE, BACTRIM DS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5030929-5
Velcade side effect was reported by a Physician from CANADA on June 06, 2006. Male patient, 66 years of age, weighting 172.2 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: agitation, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood calcium decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood pressure systolic increased. Velcade dosage: 2.60 MG, INTRAVENOUS. During the same period patient was treated with ATORVASTATIN CALCIUM, VITAMIN E, ZOPICLONE, ACETAMINOPHEN, MEPERIDINE, IMIPENEM, CEFOTAXIME, COLACE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5268771-2
Velcade side effect was reported by a Physician from JAPAN on Mar 01, 2007. Female patient, 65 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, duodenal ulcer haemorrhage, dysgeusia, malaise, thrombocytopenia, vomiting. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DEXAMETHASONE. Patient recovered.

Velcade Side Effects Report #5288286-5
Velcade side effect was reported by a Physician from JAPAN on Mar 20, 2007. Female patient, 65 years of age, was diagnosed with multiple myeloma

, thrombocytopenia. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DEXAMETHASONE. Patient recovered.

Velcade Side Effects Report #5295941-X
Velcade side effect was reported by a Physician from JAPAN on Mar 26, 2007. Female patient, 65 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood lactate dehydrogenase increased, duodenal ulcer haemorrhage, dysgeusia, malaise, thrombocytopenia, vomiting. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DEXAMETHASONE. Patient recovered.

Velcade Side Effects Report #5302221-2
Velcade side effect was reported by a Physician from JAPAN on Apr 02, 2007. Female patient, 65 years of age, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, duodenal ulcer, duodenal ulcer haemorrhage, dysgeusia, malaise, thrombocytopenia, vomiting. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with DECADRON, SULFAMETHOXAZOLE, ZANTAC, SELBEX, MAGNESIUM OXIDE, ITRACONAZOLE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5804284-4
Velcade side effect was reported by a Physician from JAPAN on June 25, 2008. Male patient, 65 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, blood urea increased, hepatic function abnormal, herpes zoster, hypoaesthesia, nausea

, platelet count decreased. Velcade dosage: 1.5 MG, INTRAVENOUS; 1.1 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PRIMPERAN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, CIPROXAN, BASEN, AMARYL, LANSOPRAZOLE. Patient recovered.

Velcade Side Effects Report #5873768-5
Velcade side effect was reported by a Physician from JAPAN on Aug 20, 2008. Male patient, 65 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, c-reactive protein increased, laboratory test abnormal, pyrexia. Velcade dosage: unknown. Patient recovered.

Velcade Side Effects Report #5874849-2
Velcade side effect was reported by a Physician from JAPAN on Aug 22, 2008. Male patient, 65 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, condition aggravated, multiple myeloma

, pleural effusion, renal failure, tumour lysis syndrome. Velcade dosage: unknown. Patient recovered.

Velcade Side Effects Report #6009123-7
Velcade side effect was reported by a Physician from JAPAN on Dec 02, 2008. Male patient, 65 years of age, weighting 160.9 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, atrial fibrillation

, blood chloride increased, blood lactate dehydrogenase increased, cardiac failure, clavicle fracture, condition aggravated, coronary artery stenosis. Velcade dosage: 2.10 MG, INTRAVENOUS; 1.6 MEQ, INTRAVENOS; 20 MG, ORAL. During the same period patient was treated with DEXAMETHASONE, SELBEX, WARFARIN, PARAMIDIN, BISOPROLOL FUMARATE, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6039413-3
Velcade side effect was reported by a Physician from JAPAN on Jan 08, 2009. Male patient, 65 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, chest pain

, condition aggravated, crystal urine present, disease progression, disorientation, infection

, malaise, malignant neoplasm progression. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with ALGINATE, VOLTAREN, NIZATIDINE, MUCOSTA, URSO, LASIX, IDOMETHINE, XYLOCAINE. Patient died on 01/02/2009.

Velcade Side Effects Report #6076292-2
Velcade side effect was reported by a Physician from JAPAN on Jan 28, 2009. Male patient, 65 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma

and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood immunoglobulin g increased, blood lactate dehydrogenase increased, c-reactive protein increased, chest pain

, disease progression, disorientation, laboratory test abnormal, malignant neoplasm progression, multiple myeloma

. Velcade dosage: 2 MG/M2, INTRAVENOUS. During the same period patient was treated with ALGINATE, VOLTAREN, NIZATIDINE, MUCOSTA, URSO, LASIX, IDOMETHINE, XYLOCAINE. Patient died on 01/02/2009.

Velcade and blood lactate dehydrogenase increased

SideEffects101.com

Velcade and blood lactate dehydrogenase increased Patient Reports March 18, 2010

side effects of Velcade